Does RANIBIZUMAB Cause Type iii immune complex mediated reaction? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Type iii immune complex mediated reaction have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.0% of all adverse event reports for RANIBIZUMAB.
5
Reports of Type iii immune complex mediated reaction with RANIBIZUMAB
0.0%
of all RANIBIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Type iii immune complex mediated reaction From RANIBIZUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Type iii immune complex mediated reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Type iii immune complex mediated reaction?
RITUXIMAB (25)
VANCOMYCIN (24)
HUMAN IMMUNOGLOBULIN G (23)
OXALIPLATIN (23)
METHOTREXATE (19)
MYCOPHENOLATE MOFETIL (18)
TACROLIMUS (18)
CYCLOPHOSPHAMIDE (17)
BORTEZOMIB (16)
CYCLOSPORINE (16)
Which RANIBIZUMAB Alternatives Have Lower Type iii immune complex mediated reaction Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE